jameslucocq Profile Banner
James Lucocq Profile
James Lucocq

@jameslucocq

Followers
91
Following
49
Media
0
Statuses
28

Surgical Registrar, BJS, BJS institute, RAMC, MFAC, MRBS Student, Medical Xcelerator

Scotland, United Kingdom
Joined January 2020
Don't wanna be here? Send us removal request.
@jameslucocq
James Lucocq
5 months
RT @sanjay_HPB: Epidemiological data on Acute Pancreatitis admissions (2013-2023) in England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 @hpbjournal .➡️Incidence of AP 456 ca….
0
11
0
@jameslucocq
James Lucocq
5 months
RT @robertson__a: Pleased to share our latest paper showing socioeconomic deprivation does not adversely affect outcomes of bariatric surge….
0
2
0
@jameslucocq
James Lucocq
7 months
RT @Gio_Marchegiani: 🔪 Open 🔦 Laparoscopic 🤖 Robot Pancreatoduodenectomy Randomised Controlled Trials. 🧮 Network Meta-Analysis on 7 RCT 1.3….
0
23
0
@jameslucocq
James Lucocq
8 months
RT @ArturZanellato: School of Surgery at RCSEd this year was magnificent. Well done all Surgical Trainees who .presented a really exciting….
0
3
0
@jameslucocq
James Lucocq
9 months
RT @EAHPBA: The E-AHPBA Scientific & Research Committee is pleased to endorse the ADENO-IPMN 2 Study with a Blue Seal of Approval! 💙. Regis….
Tweet card summary image
docs.google.com
The present study aims to determine the impact of contemporary neoadjuvant, adjuvant and palliative chemotherapy regimens on recurrence and survival outcomes in resectable, borderline resectable,...
0
7
0
@jameslucocq
James Lucocq
10 months
RT @sanjay_HPB: #Editorial @BJSurgery on Adenoca arising from IPMN #AIPMN study 459🧑🏻‍🤝‍🧑🏻.👉 5y DFS 30%.👉Rx of recurrence ⬆️ Survival.👉AdjC….
0
15
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: 👉🌎 on analgesic use in AP � 1864 🧑‍🤝‍🧑 118 centres & 27 countries.👉 Opioid use⬇️in Europe and ⬆️ As….
0
11
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: 👉🌎study on Precursor Epithelial types of MalignantIPMN and recurrence/survival after🗡️ .297 🧑‍🤝‍🧑.👉 Gastric, PB, mixed….
0
17
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: Multicenter study🌎on Long term survival after 🗡️ malignant IPMN.👉288 pts 98 m FU.👉48% recurrence with⬆️systemic recurrence….
0
15
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: Great to see @jameslucocq and @joseph_nejo give their oral presentations at @IHPBA Cape Town including one in best of the….
0
7
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: 🌎Multicenter study on Adj chemo (AC) 💊 for adenocarcinoma in IPMN.👉 18 centers & 469 patients 60% ✅AC .👉 78 m follow up .👎….
0
23
0
@jameslucocq
James Lucocq
1 year
RT @ksoreide: Great work @sanjay_HPB and team 👇🏻@AnnalsofSurgery @hpb_so @P_C_E_ Pointing to biological differences and outcomes , more to….
0
8
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: ➡️Long term outcomes PDAC versus A-IPMN.➡️18 centres 476 PDAC vs 459 A-IPMN patients.➡️Median survival Survival PDAC 19m….
0
26
0
@jameslucocq
James Lucocq
1 year
RT @sanjay_HPB: 👉🏾Prospective study on PROMs and QOL after PD at 5 time points .👉🏾Adj Chemo and post-op complications did not affect QoL….
0
12
0
@jameslucocq
James Lucocq
2 years
RT @ahmadnassar: The value of Transvesical-assisted cystic pedicle dissection. A large stone appearing at ? Hartman Pouch, ? GB neck. 1- n….
0
27
0
@jameslucocq
James Lucocq
2 years
RT @sanjay_HPB: 👉Recurrence patterns and Rx of Recurrence for Invasive #IPMN.🌏459patients 18 Pancreatic units .✅1y recurrence 23% Overall R….
0
31
0
@jameslucocq
James Lucocq
3 years
RT @PainapStudy: 2100 patients with Acute Pancreatitis recruited into PAINAP study in 3 months !!! . Potentially the largest study in lit….
0
10
0
@jameslucocq
James Lucocq
3 years
RT @giri_mks: Patient with acute gallstone pancreatitis, unfit for GA/ Lap Chole. MRCP - small stones in GB but no CBD stone. Do you procee….
0
1
0
@jameslucocq
James Lucocq
3 years
RT @SWexner: Lower-Pressure Pneumoperitoneum Decreases Post-op Pain. @gensurgnews.
0
8
0